Australia-based radiopharmaceutical company Telix Pharmaceuticals has created a new radionuclide generator that could facilitate the commercial supply of lead-212 isotope-based therapies. The company ...
This section is intended to provide hints and answers to some Frequently Asked Questions (FAQ) in relation with the activities of the International Atomic Energy Agency (IAEA) in Nuclear Medicine (NMS ...
The number of PET/CT centres is steadily increasing due to the proven high clinical utility of (F-18)FDG in cancer patients, however not all of them have direct access to a medical cyclotron. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results